Exclusive news, data and analytics for financial market professionals
Learn more about
Refinitiv
Skip to main content
Reuters home
World
Business
Markets
Sustainability
Legal
Breakingviews
Technology
Investigations
More
My View
Register
Company
Jazz Pharmaceuticals PLC
Follow
8 results
Future of Health
category
U.S. FDA calls for new regulatory framework for use of cannabis compound CBD
January 26, 2023
article with gallery
World
category
U.S. FDA weighs regulating cannabis compound CBD in food, supplements - WSJ
December 27, 2022
Business
category
Japan unit of Britain's Jazz Pharma starts phase III trial of cannabis drug
December 15, 2022
World
category
Japan health panel recommends allowing import, use of medical marijuana products
September 29, 2022
Business
category
U.S. FDA approves UCB's drug for rare childhood epilepsy
March 28, 2022
Business
category
Epilepsy drug maker Zogenix soars on UCB's potential $2 bln deal
January 19, 2022
Business
category
Spain's PharmaMar posts 58% drop in 9-mth profit despite higher revenues
October 28, 2021
Business
category
U.S. FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav
August 12, 2021
1 to 8 of 8
